| 1. | | Completed | Acamprosate Treatment: Mechanisms of Action
Condition: Alcoholism |
| 2. | | Completed | Acupuncture for Carpal Tunnel Syndrome
Condition: Carpal Tunnel Syndrome |
| 3. | | Completed | Acute Withdrawal from Smoked Cocaine - 9
Conditions: Cocaine-Related Disorders; Substance Withdrawal Syndrome; Substance-Related Disorders |
| 4. | | Recruiting | Adjuvant Nutrition for Critically Ill Trauma Patients
Condition: Trauma |
| 5. | | Completed | Akathisia (Restless Legs Syndrome) in People with Schizophrenia and Mental Retardation
Condition: Akathisia |
| 6. | | Completed | Alterations in Serotonergic Functions in Cocaine Addicts - 1
Condition: Cocaine-Related Disorders |
| 7. | | Completed | Alternate Day Buprenorphine Administration, Phase IX - 14
Condition: Opioid-Related Disorders |
| 8. | | Completed | Alternate Day Buprenorphine Administration, Phase X - 15
Condition: Opioid-Related Disorders |
| 9. | | Completed | Alternate Day Buprenorphine Administration, Phase XI - 16
Condition: Opioid-Related Disorders |
| 10. | | Completed | Alternate Day Buprenorphine Administration, Phase XII - 17
Condition: Opioid-Related Disorders |
| 11. | | Completed | Alternate-Day Buprenorphine Administration. Phase I - 3
Condition: Opioid-Related Disorders |
| 12. | | Completed | Alternate-Day Buprenorphine Administration. Phase II - 4
Condition: Opioid-Related Disorders |
| 13. | | Completed | Alternate-Day Buprenorphine Administration. Phase IV - 5
Condition: Opioid-Related Disorders |
| 14. | | Completed | Alternate-Day Buprenorphine Administration. Phase VI - 7
Condition: Opioid-Related Disorders |
| 15. | | Completed | Alternate-Day Buprenorphine Administration. Phase VII - 8
Condition: Opioid-Related Disorders |
| 16. | | Completed | Alternate-Day Buprenorphine Administration. Phase VIII - 9
Condition: Opioid-Related Disorders |
| 17. | | Completed | Alternate-Day Buprenorphine. Phase V - 6
Condition: Opioid-Related Disorders |
| 18. | | Completed | Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Conditions: adult acute myeloid leukemia; Drug Toxicity |
| 19. | | No longer recruiting | Amifostine and High-Dose Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Chronic Myelogenous Leukemia
Conditions: untreated adult acute myeloid leukemia; Drug Toxicity; secondary myelodysplastic syndrome; recurrent adult acute myeloid leukemia; ... |
| 20. | | Recruiting | Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation
Conditions: Drug Toxicity; primary systemic amyloidosis |
| 21. | | No longer recruiting | Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors
Conditions: Lung Cancer; Ovarian Cancer; Lymphoma; Leukemia; Breast Cancer |
| 22. | | Completed | Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by Chemotherapy
Conditions: Drug Toxicity; unspecified adult solid tumor, protocol specific |
| 23. | | No longer recruiting | Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
Conditions: oral complications of cancer and cancer therapy; stage IIIA non-small cell lung cancer; stage II non-small cell lung cancer; Drug Toxicity; ... |
| 24. | | Recruiting | Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors
Conditions: adult solid tumor; Breast Cancer; Lung Cancer; neurotoxicity; ovarian epithelial cancer; Prostate Cancer |
| 25. | | Recruiting | Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Gynecologic Malignancy
Conditions: Endocrine Cancer; female reproductive cancer; neurotoxicity |
| 26. | | Completed | Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer
Conditions: Endometrial Cancer; ovarian epithelial cancer; Cervical Cancer; uterine sarcoma |
| 27. | | No longer recruiting | Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer
Conditions: Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer |
| 28. | | No longer recruiting | Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer
Conditions: limited stage small cell lung cancer; Drug Toxicity; radiation toxicity |
| 29. | | No longer recruiting | Amifostine to Protect From the Side Effects of Peripheral Stem Cell Transplantation in Treating Patients With High-Risk or Relapsed Solid Tumors
Conditions: childhood soft tissue sarcoma; childhood liver cancer; adult soft tissue sarcoma; Bone Cancer; ovarian sarcoma; Testicular Cancer; Brain Tumor; ... |
| 30. | | Completed | Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer
Conditions: oral complications of cancer and cancer therapy; stage IV squamous cell carcinoma of the lip and oral cavity; ... |
| 31. | | No longer recruiting | Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
Conditions: limited stage small cell lung cancer; Drug Toxicity; radiation toxicity |
| 32. | | Completed | Amphetamine Cocaine Interaction Study - 2
Condition: Cocaine-Related Disorders |
| 33. | | Completed | Antenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage
Conditions: Intracranial Hemorrhage; Brain Injury; Brain Hemorrhage |
| 34. | | Completed | Antibiotic treatment of Gulf War Veterans' illnesses
Conditions: Persian Gulf Syndrome; Mycoplasma fermentans |
| 35. | | Recruiting | Assessment of Interactions between Methamphetamine and Aripiprazole - 1
Condition: Amphetamine-Related Disorders |
| 36. | | Recruiting | Assessment of Potential Interactions between Cocaine and RPR 102681 - 1
Condition: Cocaine-Related Disorders |
| 37. | | No longer recruiting | Assessment of Potential Interactions between Cocaine and Tolcapone - 1
Condition: Cocaine-Related Disorders |
| 38. | | No longer recruiting | Assessment of Potential Interactions between Methamphetamine and Bupropion - 1
Condition: Amphetamine-Related Disorders |
| 39. | | No longer recruiting | Assessment of Potential Interactions between Methamphetamine and Selegiline - 1
Condition: Amphetamine-Related Disorders |
| 40. | | Recruiting | Assessment of the Potential Interactions between Cocaine and GBR 12909 - 1
Condition: Cocaine-Related Disorders |
| 41. | | Recruiting | Autologous Incubated Macrophages for Patients with Complete Spinal Cord Injuries
Condition: Spinal Cord Injury |
| 42. | | Recruiting | Baclofen for the Treatment of Cocaine Dependence - 1
Condition: Cocaine-Related Disorders |
| 43. | | Recruiting | BB-10901 in Treating Patients With Recurrent or Refractory Lung Cancer, Metastatic Carcinoid Tumor, or Other Solid Tumors
Conditions: adult solid tumor; gastrointestinal carcinoid tumor; Neuroendocrine Carcinoma; Non-small cell lung cancer; pulmonary carcinoid tumor; ... |
| 44. | | Completed | Behavior and Naltrexone Treatment for Alcoholics
Condition: Alcoholism |
| 45. | | Recruiting | Behavioral Counseling for Alcohol Dependent Smokers (nicotine patch)
Conditions: Alcoholism; Smoking |
| 46. | | Completed | Behavioral Economics of Human Drug Self-Administration
Condition: Drug Dependence |
| 47. | | Recruiting | Behavioral Therapy Plus Naltrexone for Alcoholism
Condition: Alcoholism |
| 48. | | No longer recruiting | A behavioral trial for the treatment of methamphetamine dependence. - 1
Condition: Substance-Related Disorders |
| 49. | | Recruiting | Behavioral/Drug Therapy for Alcohol-Nicotine Dependence (naltrexone/nicotine patch)
Conditions: Alcoholism; Smoking |
| 50. | | Recruiting | Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Conditions: Cerebral Palsy; Intraventricular hemorrhage; Periventricular Leukomalacia; Pulmonary Edema; Abruptio Placentae |
